Health-related quality of life and symptoms among patients with relapsed or refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice: Results from a randomized phase 3 trial Meeting Abstract


Authors: Sanchorawala, V.; Wechalekar, A. D.; Kim, K.; Schönland, S.; Landau, H. J.; Fiona, K.; Suzuki, K.; Dispenzieri, A.; Merlini, G.; Comenzo, R.; Cherepanov, D.; Hayden, V. C.; Kumar, A.; Labotka, R.; Faller, D. V.; Kastritis, E.
Abstract Title: Health-related quality of life and symptoms among patients with relapsed or refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice: Results from a randomized phase 3 trial
Meeting Title: 63rd Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 138
Issue: Suppl. 1
Meeting Dates: 2021 Dec 11-14
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-23
Language: English
ACCESSION: WOS:000835740102238
DOI: 10.1182/blood-2021-148689
PROVIDER: wos
Notes: Meeting Abstract: 4771 -- Hybrid meeting, also took place online -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Heather Jolie Landau
    421 Landau